Get started
Author

Sandra Bento

Observed name: Bento, Sandra
ORCID: 0000-0002-2838-2288
Observed ORCID: 0000-0002-2838-2288
OpenAlex ID: A5102445680
Screening for a BRCA2 Rearrangement in High-Risk Breast/Ovarian Cancer Families: Evidence for a Founder Effect and Analysis of the Associated Phenotypes
2007 · Patrícia M. Machado, Rita D. Brandão, et al. · Journal of Clinical Oncology · 120
PDF
Hereditary breast cancer and ancestry in the Madeira archipelago: an exploratory study
2021 · Isália Miguel, Fátima Rodrigues, et al. · ecancermedicalscience · 8
PDF
Men seeking counselling in a Breast Cancer Risk Evaluation Clinic
2018 · Ana Catarina Freitas, Ana Opinião, et al. · ecancermedicalscience · 8
PDF
ATM germline variants and male breast cancer
2021 · Renato Cunha, Priscila Nejo, et al. · BMJ Case Reports · 5
Real-Life Experience of HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Advanced Breast Cancer Patients Treated With T-DXd (Trastuzumab Deruxtecan): A Multicentric Portuguese Study
2025 · Rita Bizarro, Isabel Pazos, et al. · Cureus · 2
Abstract P6-08-17: When BRCA2-breast cancer is more prevalent than BRCA1-breast cancer: Prospective follow-up data from a multidisciplinary program
2020 · Catarina Bexiga, Priscila Nejo, et al. · Cancer Research · 2
Bevacizumab in the treatment of metastatic breast cancer: three case reports
2011 · Ana Ferreira, Cláudia Vieira, et al. · Current Opinion in Oncology · 2
Men seeking counselling in a Breast Cancer Evaluation Clinic: fifteen years experience of a multidisciplinary program.
2016 · Ana Catarina Freitas, Ana Opiniao, et al. · Journal of Clinical Oncology · 1
Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study
2026 · Rita Quaresma Ferreira, Carolina Brandão Monteiro, et al. · European Journal of Breast Health
PDF
Testing positive after genetic testing for hereditary cancer: whatÓ?s next?
2025 · Carolina Carvalho, Diana Simão, et al. · Revista Portuguesa Oncologia
PDF
The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study
2025 · Teresa Gantes Padrão, Diana Pessoa, et al. · Clinical Breast Cancer
Comprehensive analysis of patients with cancer with a positive CHEK2 test: Are we getting closer to a genotype/phenotype correlation?
2023 · Ana Fragoso, Mafalda Melo, et al. · Journal of Clinical Oncology
PDF
Diagnosis, follow up and clinical management of individuals identified with a TP53 pathogenic variant
2022 · Sofia Fernandes, Sofia Fragoso, et al. · Medical Research Archives
PDF
Hysterectomy as a risk-reducing procedure in BRCA1 and BRCA2 women.
2022 · Ana Teresa Pina, Ana Sofia Fragoso, et al. · Journal of Clinical Oncology
Abstract P2-09-13: Is there a male breast cancer cluster region in the BRCA2 gene?
2022 · Pedro Simões, Teresa Duarte, et al. · Cancer Research
Access to breast/ovarian genetic testing: 20 years of a multidisciplinary program.
2020 · Fatima H Vaz, Teresa Duarte, et al. · Journal of Clinical Oncology
Screening for Distress in BRCA1/2 Carriers: a Prospective Study
2020 · Moura, Maria Jesus, Vaz, Fátima, et al. · Cadernos de Saúde
PDF
Beyond BRCA1 and BRCA2: Implementation of a multigene panel for the upfront testing of germline mutations in ovarian cancer.
2018 · Maria Beatriz Mira, Isalia Margarida Campos Miguel, et al. · Journal of Clinical Oncology
Somatic versus germline BRCA mutations screening in ovarian cancer.
2017 · Hugo SM Nunes, Patricia Machado, et al. · Journal of Clinical Oncology
Perguntas (mais ou menos) frequentes sobre primitivas
2017 · Patrícia Damas Beites, Sandra Bento, et al. · Educação e Matemática
PDF
Abstract P4-12-14: Distress as a measure of the psychological impact after disclosure of a BRCA1/2 positive test result
2015 · Joana Parreira, Susana Esteves, et al. · Cancer Research
Works count: 22
Citation count: 148
H-index: 4
I10-index: 1
Year
Topic
Type